Your Article Summary
Survival predictors in patients treated with a molecular adsorbent recirculating system
World Journal of Gastroenterology, 06/29/09
Kantola T et al. - The etiology of liver disease was the most important prognostic factor. MARS treatment appears to be ineffective in AOCLF with end-stage cirrhosis without an LTX option.
Related Articles
Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 71%
Drinking Coffee Slows Progression Of Liver Disease In Chronic Hepatitis C Sufferers
ScienceDaily, 10/26/09
Relevance Score: 70%
Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers
EurekAlert, 10/21/09
Relevance Score: 70%
Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09
Relevance Score: 70%
Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
Antimicrobial Agents and Chemotherapy, 11/05/09
Relevance Score: 69%
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) – lack of interference by iron deposition
British Journal of Haematology, 11/30/09
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
The Lancet Oncology - Online First, 11/30/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09

See Latest Articles